Faeth Therapeutics
Clinical trials sponsored by Faeth Therapeutics, explained in plain language.
-
New hope for advanced breast cancer: drug combo trial launches
Disease control Recruiting nowThis study tests two experimental drugs, sapanisertib and serabelisib, combined with standard therapy for people with HR+/HER2- advanced or metastatic breast cancer. The goal is to find safe doses and see if the combination can shrink tumors or slow the disease. About 32 adults w…
Phase: PHASE1, PHASE2 • Sponsor: Faeth Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New drug combo shows promise for Tough-to-Treat endometrial cancer
Disease control Recruiting nowThis study tests a new combination of drugs (sapanisertib and serabelisib, together called PIKTOR) plus standard chemotherapy (paclitaxel) in people with advanced or recurrent endometrial cancer that has not been cured by prior treatments. The goal is to see if this combo can shr…
Phase: PHASE2 • Sponsor: Faeth Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC